Christopher Tzourio

University of Bordeaux - Bordeaux Population Health Research Center

France

SCHOLARLY PAPERS

2

DOWNLOADS

78

SSRN CITATIONS

0

CROSSREF CITATIONS

1

Scholarly Papers (2)

1.

PLCG2 Protective Variant p.P522R Modulates Tau Pathology and Disease Progression in Patients with Mild Cognitive Impairment

Number of pages: 83 Posted: 02 Jan 2019
University of Cologne - Division of Neurogenetics and Molecular Psychiatry, University of Lille II - RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, University of Bonn - Institute of Innate Immunity, VU University Amsterdam - Department of Neurology, Andalusian Bioinformatics Research Centre (CAEBi), University of Cologne - Division of Neurogenetics and Molecular Psychiatry, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Bonn - Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Paris-Saclay, University of Cologne - Division of Neurogenetics and Molecular Psychiatry, University of Erlangen-Nuremberg-Friedrich Alexander Universität Erlangen Nürnberg, University of Lausanne - Department of Psychiatry, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, VU University Amsterdam - Department of Neurology, VU University Amsterdam - Department of Neurology, University of Erlangen-Nuremberg-Friedrich Alexander Universität Erlangen Nürnberg, Charité - Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy, University of Montpellier, University of Bonn, Faculty of Medicine, Department of Psychiatry and Psychotherapy, Heidelberg University - Central Institute of Mental Health, University of Bordeaux - Bordeaux Population Health Research Center, University of Bordeaux - Victor Segalen Bordeaux 2 University, University of Freiburg - Department of Rehabilitation Psychiatry and Psychotherapy, Universitat Internacional de Catalunya, Carlos III Institute of Health, Carlos III Institute of Health, Universitat Internacional de Catalunya, Universitat Internacional de Catalunya, VU University Amsterdam - Amsterdam Public Health Research Institute, University of Amsterdam - Amsterdam Public Health Research Institute, VU University Amsterdam - Amsterdam Public Health Research Institute, VU University Amsterdam - Department of Neurology, University of Goettingen (Gottingen), Faculty of Medicine, University Medical Centre, Department of Psychiatry and Psychotherapy, University of Paris-Saclay, University of Goettingen (Gottingen), Faculty of Medicine, University Medical Centre, Department of Psychiatry and Psychotherapy, Universitat Internacional de Catalunya, German Center for Neurodegenerative Diseases (DZNE), University Medical Center Hamburg-Eppendorf, University of Leipzig - Institute for Social Medicine, Occupational Health and Public Health, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Lille II - RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, German Center for Neurodegenerative Diseases (DZNE), Carlos III Institute of Health, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, Andalusian Bioinformatics Research Centre (CAEBi), University of Bonn - Institute of Innate Immunity, University of Bonn, Faculty of Medicine, Department of Psychiatry and Psychotherapy, University of Lille II - RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, VU University Amsterdam - Department of Neurology, Andalusian Bioinformatics Research Centre (CAEBi), German Center for Neurodegenerative Diseases (DZNE), Universitat Internacional de Catalunya and University of Cologne - Division of Neurogenetics and Molecular Psychiatry
Downloads 67 (349,269)

Abstract:

Loading...

2.

Age Modifies the Association Between Apolipoprotein E Genotype and Alzheimer's Disease: A CSF Biomarker-Based Multicentric Case-Control Study

Number of pages: 32 Posted: 14 Jul 2019
Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Hôpital Lariboisiere, AP-HP, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Vrije Universiteit Brussel (VUB), University of Rouen - Rouen University Hospital, Technische Universität München (TUM) - Klinikum Rechts der Isar, Göteborg University - Institute of Neuroscience and Physiology, Göteborg University - Institute of Neuroscience and Physiology, University of Perugia - Department of Medicine, University of Goettingen (Gottingen) - Department of Neurology, University of Goettingen (Gottingen) - Department of Neurology, University of Montpellier, Carlos III Institute of Health, Carlos III Institute of Health, Carlos III Institute of Health, Hôpital Lariboisiere, AP-HP, University of Antwerp - Department of Biomedical Sciences, University of Antwerp - Department of Biomedical Sciences, University of Perugia - Department of Medicine, University of Perugia - Department of Medicine, Technische Universität München (TUM), Technische Universität München (TUM), Hôpital Lariboisiere, AP-HP, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, University of Rouen - Rouen University Hospital, Hôpital Lariboisière, University of Montpellier, Hôpital Lariboisière, Lariboisiere Hospital, AP-HP, affiliation not provided to SSRN, University of Bordeaux - Bordeaux Population Health Research Center, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Hôpital Lariboisiere, AP-HP and Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases
Downloads 11 (597,268)

Abstract:

Loading...